| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 707465 | 2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- | 0.0396077140933377 | 0.18287626 |
| NSC 708416 | Null | 0.0396077140933377 | 0.49039322 |
| NSC 751644 | Null | 0.0396077140933377 | -0.16180159 |
| NSC 13477 | Null | 0.039607714093338 | -0.00051901976 |
| NSC 236657 | Cyclopent[v][1,12]oxaazacyclotetracosine-1,14(11H,22aH) -dione, 12,13,23,24-tetrahydro-23,25-dihydroxy- 24-methoxy-3,22a-dimethyl-12-phenyl- (9CI) | 0.039607714093338 | 0.34797741 |
| NSC 2805 | 2,2',5,5'-Tetrahydroxy-4,4'-dimethylbiphenyl | 0.039607714093338 | 0.13726005 |
| NSC 294846 | Cinnoline, 4-nitro-, 1-oxide | 0.039607714093338 | 0.39263277 |
| NSC 373355 | Saframycin R | 0.0403978426119736 | -0.1222522 |
| NSC 381811 | Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- | 0.0403978426119736 | 0.5547156 |
| NSC 603624 | Null | 0.0403978426119736 | 0.067176016 |